Showing 17,401 - 17,420 results of 42,114 for search '(( 5 ((we decrease) OR (nn decrease)) ) OR ( 50 ((a decrease) OR (teer decrease)) ))', query time: 0.78s Refine Results
  1. 17401

    Comparison of different classifiers with varying amounts of missing data. by Mallory Sheth (6477662)

    Published 2019
    “…We see that N-UFA is robust to missing data, with accuracy decreasing just 1.3% as the amount of missing data increases to 50%. …”
  2. 17402
  3. 17403
  4. 17404

    Trends in prostate cancer mortality in the state of São Paulo, 2000 to 2015 by Carolina Terra de Moraes Luizaga (10434025)

    Published 2021
    “…Joinpoint regression was used to calculate the average annual percent change (AAPC), with a confidence interval of 95% (95%CI), by regional network and age group (50–59, 60–69, 70–79 and 80 years or more). …”
  5. 17405

    Hypoxia-induced pulmonary remodeling. by Yuko Shirota (4351867)

    Published 2024
    “…Group1 mice showed a significant decrease in normal but increase in fully remodeled arterial walls. …”
  6. 17406

    Effect of moderate elevated intra-abdominal pressure on lung mechanics and histological lung injury at different positive end-expiratory pressures by Mascha O. Fiedler (8714205)

    Published 2020
    “…After establishing the intra-abdominal pressure, we randomized the animals into 3 groups. Each of n = 6 (Group A = PEEP 5, B = PEEP 10 and C = PEEP 15 cmH<sub>2</sub>O). …”
  7. 17407

    Effects of Shenfu injection on shivering prevention and hemodynamic impact in elderly patients underwent transurethral resection of the prostate by Weiqi KE (10464517)

    Published 2021
    “…Patients in the experiment group had lower incidence of shivering (10% in the experiment group versus 27.5% in the control group, p = 0.042). On average, patients in the experiment group had significantly more stable hemodynamic parameters: with lower heart rate, less decrease in systolic and diastolic blood pressure (p < 0.05 for all). …”
  8. 17408

    The Brazilian National Immunization Program: 46 years of achievements and challenges by Carla Magda Allan Santos Domingues (10389186)

    Published 2021
    “…As a result, many people have no notion of the danger these diseases represent. We thus need to understand the multiple factors contributing to this decrease in coverage, which has created the risk of resurgence of serious diseases that had already been controlled or eliminated in Brazil.…”
  9. 17409

    Estimated demographic history in four simple demographic scenarios with selfing. by Thibaut Paul Patrick Sellinger (8677419)

    Published 2021
    “…We have <i>σ</i> = 0 (red), 0.5 (blue), 0.8 (green) and 0.9 (purple). …”
  10. 17410

    DataSheet_1_The role of involved field irradiation versus elective nodal irradiation in definitive radiotherapy or chemoradiotherapy for esophageal cancer- a systematic review and... by Hesong Wang (737012)

    Published 2022
    “…</p>Conclusions<p>Compared to ENI, IFI demonstrated significant improvement in OS at 5 years. The addition of intensity-modulated radiotherapy (IMRT) to IFI increased the 5-year OS; however, similar results were not observed with the addition of three-dimensional conformal radiotherapy to IFI and ENI. …”
  11. 17411
  12. 17412
  13. 17413

    Intravesical MIF and MIF receptors mediate PAR4-induced bladder hyperalgesia. by Shaojing Ye (11320474)

    Published 2021
    “…A) In mice pre-treated with intravesical PBS, intravesical PAR4 peptide resulted in a marked and significant decrease in 50% threshold score when compared to scrambled peptide treatment. …”
  14. 17414

    Image_1_A Fenton-like cation can improve arsenic trioxide treatment of sclerodermatous chronic Graft-versus-Host Disease in mice.tif by Charlotte Chêne (11221620)

    Published 2022
    “…In vivo, in a cGvHD mouse model, daily injections of ATO 2.5 µg/g + CuCl<sub>2</sub> 0.5 µg/g induce a decrease in lymphocyte activation and fibrosis that was equivalent to that induced by ATO 5 µg/g. …”
  15. 17415

    Image_4_A Fenton-like cation can improve arsenic trioxide treatment of sclerodermatous chronic Graft-versus-Host Disease in mice.tif by Charlotte Chêne (11221620)

    Published 2022
    “…In vivo, in a cGvHD mouse model, daily injections of ATO 2.5 µg/g + CuCl<sub>2</sub> 0.5 µg/g induce a decrease in lymphocyte activation and fibrosis that was equivalent to that induced by ATO 5 µg/g. …”
  16. 17416

    Image_6_A Fenton-like cation can improve arsenic trioxide treatment of sclerodermatous chronic Graft-versus-Host Disease in mice.tif by Charlotte Chêne (11221620)

    Published 2022
    “…In vivo, in a cGvHD mouse model, daily injections of ATO 2.5 µg/g + CuCl<sub>2</sub> 0.5 µg/g induce a decrease in lymphocyte activation and fibrosis that was equivalent to that induced by ATO 5 µg/g. …”
  17. 17417

    Table_1_A Fenton-like cation can improve arsenic trioxide treatment of sclerodermatous chronic Graft-versus-Host Disease in mice.pdf by Charlotte Chêne (11221620)

    Published 2022
    “…In vivo, in a cGvHD mouse model, daily injections of ATO 2.5 µg/g + CuCl<sub>2</sub> 0.5 µg/g induce a decrease in lymphocyte activation and fibrosis that was equivalent to that induced by ATO 5 µg/g. …”
  18. 17418

    Image_2_A Fenton-like cation can improve arsenic trioxide treatment of sclerodermatous chronic Graft-versus-Host Disease in mice.tif by Charlotte Chêne (11221620)

    Published 2022
    “…In vivo, in a cGvHD mouse model, daily injections of ATO 2.5 µg/g + CuCl<sub>2</sub> 0.5 µg/g induce a decrease in lymphocyte activation and fibrosis that was equivalent to that induced by ATO 5 µg/g. …”
  19. 17419

    DataSheet1_Saccharomyces cerevisiae surface display of endolysin LysKB317 for control of bacterial contamination in corn ethanol fermentations.PDF by Shao-Yeh Lu (9355095)

    Published 2023
    “…Yeast surface-expressed endolysin demonstrated an 83.8% decrease in bacterial cell counts compared to a 9.5% decrease in control yeast. …”
  20. 17420

    Image_3_A Fenton-like cation can improve arsenic trioxide treatment of sclerodermatous chronic Graft-versus-Host Disease in mice.tif by Charlotte Chêne (11221620)

    Published 2022
    “…In vivo, in a cGvHD mouse model, daily injections of ATO 2.5 µg/g + CuCl<sub>2</sub> 0.5 µg/g induce a decrease in lymphocyte activation and fibrosis that was equivalent to that induced by ATO 5 µg/g. …”